Carter Van Waes
- Cancer Research top 5%
- NF-κB Signaling Pathways 6
- Oncology top 5%
- Chemokine receptors and signaling 3
- Peptidase Inhibition and Analysis 3
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 5
- Otorhinolaryngology top 5%
- Immunology top 10%
- Immunotherapy and Immune Responses 5
- interferon and immune responses 3
-
- Fibroblast Growth Factor Research 3
- Cell death mechanisms and regulation 3
- Co-authors
- Zhong ChenJohn B. SunwooNing T. YehGuo‐Chung DongC C BancroftJulian AdamsEdward A. SausvillePeter J. Elliott
- Journals
- Journal of Biological Chemistry (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Cancer Research (3 papers)
- Partner nations
- United StatesJapanMalaysia
In The Last Decade
Carter Van Waes
27 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 408
- Oncology 647
- Immunology and Allergy 122
- Otorhinolaryngology 75
- Immunology 321
Countries citing papers authored by Carter Van Waes
This map shows the geographic impact of Carter Van Waes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carter Van Waes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carter Van Waes more than expected).
Fields of papers citing papers by Carter Van Waes
This network shows the impact of papers produced by Carter Van Waes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carter Van Waes. The network helps show where Carter Van Waes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carter Van Waes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2018 | 24 | |
| 3 | 2015 | 47 | |
| 4 | 2015 | 25 | |
| 5 | 2011 | 44 | |
| 6 | 2011 | 50 | |
| 7 | 2009 | 46 | |
| 8 | 2009 | 1 | |
| 9 | 2008 | 64 | |
| 10 | 2007 | 47 | |
| 11 | 2007 | 4 | |
| 12 | 2006 | 14 | |
| 13 | 2004 | 66 | |
| 14 | 2001 | 40 | |
| 15 | IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. | 2001 | 193 |
| 16 | Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. | 2001 | 393 |
| 17 | 2000 | 16 | |
| 18 | 1999 | 1 | |
| 19 | 1993 | 11 | |
| 20 | 1993 | 29 |
About Carter Van Waes
Carter Van Waes is a scholar working on Immunology and Allergy, Oncology and Cancer Research, having authored 28 papers that have together received 1.5k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (6 papers), Immunotherapy and Immune Responses (5 papers), Cell Adhesion Molecules Research (5 papers), interferon and immune responses (3 papers), Fibroblast Growth Factor Research (3 papers), Chemokine receptors and signaling (3 papers), Cell death mechanisms and regulation (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (408 citations), Oncology (647 citations) and Immunology and Allergy (122 citations). Carter Van Waes has collaborated with scholars based in United States, Japan and Malaysia. Frequent co-authors include Zhong Chen, John B. Sunwoo, Ning T. Yeh, Guo‐Chung Dong, C C Bancroft, Julian Adams, Edward A. Sausville, Peter J. Elliott, Zhong Chen and TL Lee. Their work appears in journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.